Gregory Y H Lip Selected Research

Anti-Arrhythmia Agents

1/2023	Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK.
1/2022	Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry.
1/2022	Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial.
11/2021	Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
1/2021	Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: A report from the Chinese Atrial Fibrillation Registry study.
12/2019	In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs.
12/2018	Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
3/2017	Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
1/2016	Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy.
5/2014	ACP Journal Club. Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory Y H Lip Research Topics

Disease

967	Atrial Fibrillation 05/2024 - 01/2002
618	Stroke (Strokes) 05/2024 - 01/2002
485	Hemorrhage 05/2024 - 01/2002
183	Ischemic Stroke 06/2024 - 12/2004
175	Heart Failure 06/2024 - 11/2002
135	Hypertension (High Blood Pressure) 04/2024 - 07/2002
122	Thromboembolism 02/2024 - 05/2003
119	Embolism (Embolus) 05/2024 - 09/2004
119	Myocardial Infarction 03/2024 - 11/2002
104	Thrombosis (Thrombus) 05/2024 - 01/2002
100	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 01/2002
67	Acute Coronary Syndrome 06/2024 - 12/2002
62	Inflammation (Inflammations) 03/2024 - 09/2002
55	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 03/2011
50	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 12/2003
48	Diabetes Mellitus 10/2023 - 08/2003
48	Vascular Diseases (Vascular Disease) 03/2023 - 06/2004
43	Chronic Renal Insufficiency 04/2024 - 02/2004
42	Cardiac Arrhythmias (Arrythmia) 01/2023 - 12/2002
41	Neoplasms (Cancer) 04/2024 - 09/2002
39	Venous Thromboembolism 01/2024 - 10/2002
39	Transient Ischemic Attack 10/2023 - 06/2008
30	COVID-19 01/2024 - 01/2020
25	Dementia (Dementias) 05/2024 - 10/2012
23	Type 2 Diabetes Mellitus (MODY) 04/2024 - 08/2004
23	Atherosclerosis 01/2024 - 02/2002
22	Peripheral Arterial Disease 03/2024 - 04/2003
19	Heart Diseases (Heart Disease) 04/2024 - 02/2004
16	Coronary Disease (Coronary Heart Disease) 05/2023 - 03/2003
16	Fibrosis (Cirrhosis) 01/2023 - 05/2003
13	ST Elevation Myocardial Infarction 06/2024 - 06/2009
13	Obesity 02/2024 - 09/2006
13	Systolic Heart Failure 01/2017 - 08/2004
12	Cerebral Hemorrhage 02/2024 - 09/2011
11	Frailty 04/2024 - 01/2018
11	Body Weight (Weight, Body) 07/2023 - 09/2006
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 05/2006
10	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 05/2003
10	Pulmonary Embolism 11/2023 - 01/2003
10	Mitral Valve Stenosis (Mitral Stenosis) 07/2023 - 05/2012

Drug/Important Bio-Agent (IBA)

516	AnticoagulantsIBA 05/2024 - 10/2003
332	Warfarin (Coumadin)FDA LinkGeneric 05/2024 - 01/2002
301	Vitamin K FDA Link 05/2024 - 09/2004
154	Dabigatran FDA Link 05/2024 - 03/2010
146	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024 - 08/2002
117	RivaroxabanIBA 05/2024 - 03/2007
117	apixabanIBA 05/2024 - 09/2008
72	N(4)-oleylcytosine arabinosideIBA 05/2024 - 11/2013
72	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2004
68	edoxabanIBA 12/2023 - 01/2012
53	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2024 - 12/2003
51	von Willebrand FactorIBA 01/2018 - 07/2002
42	omega-Chloroacetophenone (Mace)IBA 06/2024 - 02/2008
38	Clopidogrel (Plavix)FDA Link 12/2023 - 08/2002
35	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2006
33	P-SelectinIBA 01/2017 - 05/2002
32	C-Reactive ProteinIBA 03/2024 - 06/2003
28	CreatinineIBA 02/2024 - 02/2004
27	LipidsIBA 04/2024 - 08/2003
27	Factor Xa InhibitorsIBA 10/2023 - 03/2007
25	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2004
25	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 02/2002
23	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2003
21	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 09/2004
21	Anti-Arrhythmia AgentsIBA 01/2023 - 07/2004
20	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2023 - 04/2015
20	AntithrombinsIBA 10/2021 - 01/2005
20	E-SelectinIBA 01/2017 - 06/2003
18	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2003
17	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2024 - 11/2002
17	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2003
17	Thromboplastin (Tissue Factor)IBA 01/2019 - 09/2002
16	FibrinIBA 05/2024 - 07/2003
15	CholesterolIBA 05/2024 - 08/2003
15	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2006
14	SodiumIBA 04/2024 - 09/2003
13	Heparin (Liquaemin)FDA LinkGeneric 08/2023 - 09/2004
13	AcenocoumarolIBA 03/2018 - 07/2011
12	TicagrelorIBA 12/2023 - 01/2012
12	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2003
11	Angiotensin Receptor AntagonistsIBA 04/2024 - 11/2002
11	Thrombin FDA Link 01/2018 - 12/2004
11	Matrix Metalloproteinases (MMPs)IBA 01/2012 - 01/2004
10	Digoxin (Digitek)FDA LinkGeneric 12/2023 - 12/2007
10	AngiopoietinsIBA 08/2009 - 02/2004
9	Proton Pump InhibitorsIBA 03/2024 - 08/2015
9	Amiodarone (Amiodarona)FDA LinkGeneric 12/2023 - 05/2003

Therapy/Procedure

546	Therapeutics 04/2024 - 01/2002
86	Percutaneous Coronary Intervention 12/2023 - 12/2002
51	Electric Countershock (Cardioversion) 01/2024 - 08/2004
48	Catheter Ablation 02/2024 - 12/2009
47	Secondary Prevention 01/2024 - 05/2003
43	Stents 07/2022 - 02/2008
27	Drug Therapy (Chemotherapy) 04/2024 - 10/2003
20	Patient Readmission 11/2023 - 05/2011
14	Cardiac Rehabilitation 06/2024 - 09/2003
13	Polypharmacy 04/2024 - 05/2016
10	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 08/2023 - 05/2008
10	Defibrillators (Defibrillator) 01/2023 - 09/2009
9	Length of Stay 01/2024 - 04/2012